Drugs / Sultamicillin
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01892488 | Jun 2013 → Apr 2019 | chronic obstructive pulmonary disease | Hannover Medical School | Completed | No outcome recorded |
| Phase 4 | NCT01118403 | Mar 2011 | — | Hospital Pablo Tobón Uribe | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sultamicillin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01118403 ↗ |
| Route | Intravenous | “three grams intravenously every 6 hours” NCT01118403 ↗ |